The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Night Blindness Treatment Market Expected To Change From 2026 To 2030?
The night blindness treatment market size has experienced significant expansion in recent years. It is forecast to grow from $4.2 billion in 2025 to $4.46 billion in 2026, at a compound annual growth rate (CAGR) of 6.3%. This growth in the preceding period can be linked to a high incidence of malnutrition, limited availability of eye care services, increasing recognition of vision disorders, an expanding elderly population, and advancements in ophthalmic diagnostics.
The night blindness treatment market is projected to experience substantial expansion over the coming years, with its size expected to reach $5.66 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This anticipated growth can be attributed to several factors including rising investment in eye health programs, increasing demand for personalized treatments, the expansion of gene therapy applications, growth in healthcare infrastructure, and improving reimbursement policies. Major trends during the forecast period include the rising prevalence of vitamin A deficiency, increasing adoption of early diagnosis techniques, growth in minimally invasive eye surgeries, expanding use of nutritional and preventive therapies, and improved access to vision care in emerging economies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18413&type=smp
Which Drivers Are Supporting The Night Blindness Treatment Market Growth?
The increasing occurrence of cataracts is projected to boost the expansion of the night blindness treatment market in the future. Cataracts are a condition where the eye’s lens becomes opaque, leading to vision impairment. Their development is linked to increased exposure to ultraviolet (UV) light from the sun, smoking, and an unhealthy diet. Cataracts diminish the eye’s ability to differentiate between various light and dark shades, which is vital for seeing at night. This reduced contrast sensitivity complicates navigation and object recognition in dim environments. For example, in May 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that hospital admissions for cataract surgery in England surged to over 516,000 in the financial year ending 2023, equivalent to 4,679 per 100,000 people, a notable rise from the previous year’s rate of 3,803 per 100,000. Consequently, the rising prevalence of cataracts is fueling the night blindness treatment market.
Which Segment Categories Are Included In The Night Blindness Treatment Market Segment Analysis?
The night blindness treatment market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Other Treatments
2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses
3) By Symptom: Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms
4) By End User: Clinic, Hospital, Other End Users
Subsegments:
1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications
2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery
3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy
Which Trends Are Expected To Impact The Night Blindness Treatment Market?
Key companies active in the night blindness treatment sector are developing cutting-edge genetic therapies to address the fundamental genetic mutations responsible, aiming to boost treatment efficacy for better patient experiences. Genetic therapies function by targeting and mending specific genetic mutations that disrupt retinal function, potentially restoring vision for individuals with inherited retinal disorders suchibilities as retinitis pigmentosa. For example, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, unveiled HG004, a gene therapy formulated to treat inherited retinal diseases including Leber’s congenital amaurosis. This therapy has demonstrated its advantage over current treatments in preclinical studies, with the objective of restoring retinal function and easing night blindness and other conditions associated with RPE65-induced impairments.
Who Are The Active Companies Shaping The Night Blindness Treatment Market?
Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann‑La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc.
Get The Full Night Blindness Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report
Where Is The Night Blindness Treatment Market Primarily Concentrated By Region?
North America was the largest region in the night blindness treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Night Blindness Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report
Browse Through More Reports Similar to the Global Night Blindness Treatment Market 2026, By The Business Research Company
Alpers Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/alpers-disease-treatment-global-market-report
Rare Inflammatory Disease Treatment Market Report
Rare Neurological Disease Treatment Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model